Company patents
Cytokinetics, Inc.
Cytokinetics, Inc. demonstrates a strong focus on core pharmaceutical innovation, with Heterocyclic Compounds representing a dominant 78.9% of its portfolio, experiencing an 80.0% YoY growth in 2024 before a decline in 2025 and 2026 (so far). While Pharmaceutical Preparations saw an 83.3% YoY surge in 2025, the significant drop in patenting activity across most categories so far in 2026, including a 100.0% decline in Electrotherapy / Radiation Therapy, suggests a potential shift in R&D priorities or a natural fluctuation in patent filing cycles.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
57 US filings (since 2023) · 7 categories · 7 themes
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Techniques for preparing and characterizing specific solid forms, such as crystal forms, salts, co-crystals, or amorphous forms, of active pharmaceutical ingredients to optimize properties like stability, solubility, and bioavailability.
Development of lipid-based nanoparticles, liposomes, or other molecular platforms to encapsulate and deliver therapeutic agents, particularly nucleic acids, to target tissues or improve pharmacokinetics.
Development of small molecules, often bifunctional (e.g., PROTACs) or molecular glues, that induce the ubiquitin-proteasome system or autophagy to selectively degrade specific disease-causing proteins.
Processes and methodologies for the efficient and scalable preparation of complex heterocyclic compounds and their precursors, including specific reaction conditions, purification techniques, and intermediate compounds.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Systems that provide therapeutic stimulation or field therapy through wearable devices, often incorporating physiological sensing and closed-loop feedback for personalized and adaptive treatment.
Patents
Showing 1-10 of 20
API Solid Form Engineering